Mental Illness Psychotherapy Drug Task Force

What is Psychotherapy and How Does it Work?

Sep 9, 2022 | Research

You may have heard of it, but what is psychotherapy and how does it work? According to the National Institute of Mental Health, a staggering 52.9 million adults in the United States suffer from some form of mental illness. That’s almost one in every five people. Many...

FDA Anticipated to Approve Psilocybin for Depression Within 2 Years

Aug 24, 2022 | In the News

The FDA is anticipated to approve psilocybin as a therapeutic drug to treat depression within the next two years. This news comes from an official letter sent by the Substance Abuse and Mental Health Services Administration. The letter has many interesting statements,...

What is Utah’s Mental Illness Psychotherapy Drug Task Force?

Aug 22, 2022 | Legal Update

Utah’s Mental Illness Psychotherapy Drug Task Force is active and operating, but what is it? What is the task force doing? Who is on the task force, and why was it formed in the first place? You can find the answers to all of these questions below as we take a closer...

What is Utah HB 167 and How Can it Help People in Utah?

Aug 17, 2022 | Legal Update

Utah HB 167 is a House Bill that established the Mental Illness Psychotherapy Drug Task Force. HB 167 was first introduced in January, by Rep. Brady Brammer, where it passed both chambers of the legislature. The bill garnered almost unanimous support on both sides of...